Category: Featured Story
-
Sloan-Kettering “Pioneering” Use of MRI To Quickly, Accurately Determine Effectiveness of Cancer Treatment
Memorial Sloan-Kettering Cancer Center is dedicated to excellence in the prevention, treatment, and cure of cancer – and the center is continually innovating to achieve that goal. Last month, MesotheliomaHelp reported on the Center’s new approach to clinical trials using “Basket Studies.” Now, MSKCC is leading the way by appraising an innovative tool that can …
Label: Featured Story
Posted on Monday, Oct 12, 2015 -
Phase II Clinical Trial Stabilizes Peritoneal Mesothelioma Patients
Mesothelioma, a rare cancer with just 3,000 cases diagnosed in the U.S. each year, is under-represented in the medical community. Peritoneal mesothelioma, a cancer of the abdomen, is even rarer, representing just ten percent of all mesothelioma patients. Now, the disease is receiving some much-needed attention with several recent studies pointing to successful treatments. In …
Label: Featured Story
Posted on Thursday, Oct 8, 2015 -
Cuban Cancer Vaccine Offers Hope to Mesothelioma and Lung Cancer Patients
When President Obama opened the doors to trade with Cuba this year, he gave the U.S. access to a promising lung cancer vaccine developed in Cuba. The country has developed the first vaccine, being called a “game changer,” shown to be effective against lung cancer. Now, many oncologists and mesothelioma specialists are watching closely in …
Label: Featured Story
Posted on Thursday, Sep 24, 2015